Skip to content

3D Printing in Compounding: One Pharmacy's Journey and a Discussion for the Industry | CurifyLabs Podcast Series

Pharmacy Podcast Network

24m
Transcript

Original podcast

Where to listen

Summary

Written by a model from the transcript; not yet reviewed.

This episode explores the integration of 3D printing and advanced technology in non-sterile compounding pharmacies, featuring insights from Tanil Davis of the Alliance for Pharmacy Compounding and independent pharmacy owner T.W. Taylor. The discussion examines how compounding printers improve precision, repeatability, and time efficiency compared to manual methods, while addressing regulatory considerations, third-party testing, and safety protocols. The conversation also highlights practical business applications, including veterinary care expansion, hormone replacement therapies, and marketing strategies for independent community pharmacies.

  • Independent pharmacies can leverage 3D printing technology to drastically reduce batch production time for items like veterinary treats. 8:14
  • Compounding pharmacists must ensure regular machine calibration and maintenance, treating built-in analytical scales just like any other scale. 15:51
  • Technology enables precise dosing titration in quarters or thirds for high-volume medications like low-dose naltrexone. 11:20
  • Pharmacies can expand into cash-based veterinary compounding by utilizing new dosage forms such as films or gummies instead of traditional tiny tabs. 17:41

Chapters

  1. 0:05
    Podcast Introduction and Host Overview

    The episode opens with the hosts welcoming listeners and introducing the podcast series and its partners.

  2. 2:21
    Safety and Compliance in Advanced Compounding

    Discussion centers on how new technologies impact safety, compliance, and the traditional focus on ingredients.

  3. 3:18
    Evolution of Compounding Technology

    The panel reviews the progression from manual capsule packing to AI-driven formulation and routine pharmacy tasks.

  4. 4:25
    Impact of 3D Printing on Non‑Sterile Compounds

    T W Taylor explains how the Curify Labs printer improves speed, consistency, and reduces waste in non‑sterile compounding.

  5. 7:27
    Marketing and Community Engagement Strategies

    Strategies for communicating new technologies to patients, veterinarians, and physicians are shared, emphasizing personal contact and trust.

  6. 8:46
    Quality Assurance and Validation Practices

    The conversation covers routine testing, calibration, and regulatory considerations for 3D‑printed compounding equipment.

  7. 12:48
    Business Expansion Opportunities

    Exploration of new product lines—pet treats, peptide films, and ED medication films—and how they can grow pharmacy services.

  8. 14:48
    Regulatory Landscape and Standardization

    Panelists discuss the lack of current standards for 3D printers and how pharmacists must maintain oversight and calibration.

  9. 23:02
    Closing Remarks and Future Directions

    Hosts thank guests, highlight upcoming regulatory updates, and invite listeners to engage with the podcast network.

Highlights

  • 2:54

    Evolution From Wild West Compoundinginsight

    Tanil Davis explains how compounding has shifted from hand-packing capsules in 1997 to utilizing advanced tools and AI systems, moving away from the old Wild West era.

  • 5:42

    Precision Measurement Comparisoninsight

    Tanil Davis notes that the repeatability of 3D printer measurements is much more precise than manual compounding, though it remains a supplement to, not a replacement for, pharmacist judgment.

  • 8:14

    Speed and Repeatability of Printingstory

    T.W. Taylor shares that printing 120 veterinary treats took about 10 minutes, noting that every printed item weighs the exact same, eliminating capsule packing variations.

  • 12:38

    Formulation Limitations in Softwaredebate

    T.W. Taylor highlights a current challenge where pharmacy management software limits dose adjustments compared to what the printer and its software are capable of producing.

  • 13:39

    Expanding Peptides Into Filmsstrategy

    T.W. Taylor discusses how certain small-molecule peptides could be administered via oral mucosa films rather than injections, avoiding the need for a sterile lab.

  • 18:00

    Hosting Practitioner Open Housesstrategy

    T.W. Taylor details his strategy of hosting multi-night open houses at the pharmacy for veterinarians and physicians to demonstrate the 3D printer and gather feedback.

  • 22:36

    USP Seeks Alternative Technology Commentsdata

    Tanil Davis announces that the United States Pharmacopeia is requesting comments by the end of November on using alternative technologies for process validation.

Quotes

  • “So, compounding pharmacies are becoming more and more sophisticated in their techniques for compounding and the tools that they use in, you know, the AI systems that are being employed for both formulation development and even routine pharmacy tasks.”
    Unnamed speaker · 3:18
  • “I did not buy a 3D printer. I bought a time-saving machine.”
    Unnamed speaker · 4:53
  • “We printed 120 treats in about 10 minutes.”
    Unnamed speaker · 8:14
  • “The repeatability of the measurements is impressive for them, these kind of machines to make oil-filled capsules, suppositories, lozenges, trokeys, anything that requires a repeatable measurement is, is quite impressive.”
    Unnamed speaker · 6:11
  • “I love the meticulousness of our compounding pharmacists married to technology and innovation, and then turning that around, marketing it to our communities.”
    Unnamed speaker · 19:44
  • Curify Labs 0:26–1:13

About this episode

In Part One of the CurifyLabs Podcast Series, “Trust, Technology & the Future of Compounding,” Pharmacy Podcast Network host Todd Eury is joined by Tenille Davis, PharmD, Chief Advocacy Officer for the Alliance for Pharmacy Compounding (APC), and T. W. Taylor, PharmD, Owner of Williamsburg Drug Co. for a timely conversation about responsible innovation, compliance, and the evolving future of personalized medicine. Together, they explore the state of the compounding industry, opportunities for independent compounding pharmacies, and how pharmacists should evaluate emerging technologies as automation becomes increasingly integrated into pharmacy workflows. The discussion also examines what truly determines compounded dose quality, including the roles of validation, documentation, repeatability, traceability, formulation homogeneity, dispensing accuracy, and pharmacist oversight. Todd and Tenille separate meaningful evidence from marketing claims through “Fact Check: Compounding Edition,” addressing misconceptions such as whether mass uniformity equals content uniformity and whether greater automation automatically means greater quality. The episode sets the foundation for the CurifyLabs series with a central message: the future of compounding depends on bringing technology, evidence, compliance, and pharmacist expertise together to advance personalized patient care responsibly.

Transcript

0:00
24:25

3,643 words · 4 speakers

Topics

  • LDN
  • Trokeys
  • Pharmacy Podcast Network
  • Progesterone
  • Pioneer
  • Eagle
  • APC
  • Virginia
  • Williamsburg
  • Williamsburg Drug Company

Page updated · transcript and summary are machine-generated